Biotech Investors & VC Firms in Asia-Pacific
571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.
GrainCorp Ventures
SydneySeed–Series B$500K – $4M
1 person
ID Ventures
SeoulSeed–Series A
Medical Incubator Japan K.K.
TokyoSeries A–Series B
Stone Bridge Ventures
SeoulSeed–Late Stage$1.4M – $19M
Baidu Ventures
BeijingPre-Seed–Growth$1.4M – $145M
Sherpa Healthcare Partners
Grand CaymanSeed–Late Stage
3 people
TAYA Venture Capital
New Taipei CityPre-Seed–Growth
5 people
WONIK Investment Partners
SeoulSeries A–Late Stage
11 people
Quad Ventures
SeoulPre-Seed–Late Stage
4 people
MPCi (formerly Matrix Partners China)
SingaporeSeed–Growth
11 people
PacBridge Capital Partners
Hong KongSeed–Growth
5 people
PrimeStreet Capital
Bangkok
5 people
Vision Incubate
KanazawaPre-Seed–Growth
Shanghai Creation Investment
ShanghaiLate Stage
Trinity Innovation Bioventure Singapore
SingaporeSeed–Late Stage
3 people
Tarnagulla Ventures
MelbournePre-Seed–Series A
2 people
Brandon BioCatalyst
MelbournePre-Seed–Series A
1 person
Majuven
SingaporeSeed–Late Stage
4 people
South China Venture Capital
ShenzhenSeed–Late Stage
4 people
Vision Ventures
SeoulSeed–Series A
47 Ventures
New YorkPre-Seed–Growth$150K – $2M
1 person
Capital Angels
CanberraPre-Seed–Seed$6.5K – $16.5K
1 person
B Current Impact Investment
TaipeiSeed–Series A
Hangzhou Industrial Investment Group
Hangzhou
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.




.jpg)



















